Introvision for Migraine and Headaches
Introvision for Migraine and Headaches
To evaluate the effect of Introvision, a mental and emotional self-regulation-technique
 developed by Angelika C. Wager, as migraine preventative compared to a waiting list group.
Randomized, single-center, waiting-list control group study: Introvision as preventative in
 Migraine

 Randomized, single center, waiting-list group control study to evaluate the effect of
 Introvison, a mental and emotional self regulation method to reduce headache days in patients
 with migraine, migraine and tension type headache and chronic migraine. The number of
 headache days 3 months after completion of the last session of Introvision will be compared
 with the number of headache days of the waiting list group in the month before the course to
 learn Introvision.
Inclusion Criteria:

 -  Episodic migraine with at least 5 headache days per month, episodic migraine and
 tension type headache with at least 5 migraine headache days per month, chronic
 migraine

 -  Stable prophylactic headache medication

 -  Stable non-medication headache prophylaxis (sports, relaxation techniques, …)

 -  Informed consent

 Exclusion Criteria:

 -  Other causes of headache, symptomatic headaches

 -  Other primary headaches such as Cluster headache, trigeminal neuralgia, idiopathic
 facial pain, new daily persistent headache

 -  Severe depression (more than 13 points in the Beck Depression inventory fast screen
 (BDI-FS)

 -  Drug - or alcohol abuse

 -  Non-compliance, especially significant missing entries in the headache diaries

 -  Active psychosis